This study looks at the effects of a drug called Auxora in people with acute kidney injury (AKI) and breathing problems known as acute hypoxemic respiratory failure (AHRF). AKI means the kidneys suddenly stop working well, and AHRF means having very low oxygen levels in the blood. Up to 150 patients will participate, with some receiving Auxora and others a placebo, which looks the same but has no active medicine. The study will have 5 drug infusions over 5 days. Both doctors and patients won't know who is getting Auxora or the placebo.
- The study lasts until Day 90 with regular hospital checks.
- Participants must be at least 18 and have Stage 2 or 3 AKI.
- Pregnant or nursing women cannot participate.
How understandable was the trial content above?
Hard to understand
Easy to understand